09:48 AM EST - Knight Therapeutics Inc. : Reported financial results for its third quarter ended September 30, 2018. Revenues were $3,220, an increase of $1,360 or 73% over prior-year period. Net income was $12,930, an increase of $9,337 or 260% over prior-year period. Cash outflow from operations of $19,916 compared to cash inflows of $10,736 in prior year.Cash, cash equivalents, and marketable securities of $775,046 as at September 30, 2018. Knight Therapeutics Inc.
shares T.GUD are trading up $0.01 at $8.11.
